Tag Archives: HRTX

Best Value Stocks For 2019

Leave a reply

Strategic Wealth Partners Ltd. raised its position in shares of Leggett & Platt, Inc. (NYSE:LEG) by 4,730.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,530 shares of the company’s stock after purchasing an additional 20,105 shares during the period. Strategic Wealth Partners Ltd.’s holdings in Leggett & Platt were worth $916,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of LEG. SG Americas Securities LLC raised its position in Leggett & Platt by 17.6% during the 1st quarter. SG Americas Securities LLC now owns 15,110 shares of the company’s stock valued at $670,000 after purchasing an additional 2,257 shares in the last quarter. Mackay Shields LLC bought a new stake in Leggett & Platt during the 1st quarter valued at $984,000. Victory Capital Management Inc. raised its position in Leggett & Platt by 16.2% during the 1st quarter. Victory Capital Management Inc. now owns 260,140 shares of the company’s stock valued at $11,540,000 after purchasing an additional 36,287 shares in the last quarter. BlackRock Inc. raised its position in Leggett & Platt by 1.2% during the 1st quarter. BlackRock Inc. now owns 12,608,640 shares of the company’s stock valued at $559,321,000 after purchasing an additional 145,889 shares in the last quarter. Finally, Federated Investors Inc. PA bought a new stake in Leggett & Platt during the 1st quarter valued at $138,000. 77.40% of the stock is owned by institutional investors and hedge funds.

Best Value Stocks For 2019: ConnectOne Bancorp, Inc.(CNOB)

Advisors’ Opinion:

  • [By Max Byerly]

    ConnectOne Bancorp Inc (NASDAQ:CNOB) has been assigned an average rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $33.50.

  • [By Ethan Ryder]

    Media headlines about Center Bancorp (NASDAQ:CNOB) have trended somewhat positive on Tuesday, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Center Bancorp earned a news impact score of 0.09 on Accern’s scale. Accern also assigned press coverage about the financial services provider an impact score of 47.8586921520597 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Best Value Stocks For 2019: Home Bancorp, Inc.(HBCP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Beneficial Bancorp (NASDAQ: BNCL) and Home Bancorp (NASDAQ:HBCP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

  • [By Ethan Ryder]

    Media stories about Home Bancorp (NASDAQ:HBCP) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Home Bancorp earned a news impact score of 0.02 on Accern’s scale. Accern also gave press coverage about the bank an impact score of 47.6769620242767 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Home Bancorp (HBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Home Bancorp (HBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Home Bancorp (HBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Value Stocks For 2019: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday was a poor day on Wall Street, with major benchmarks giving up about 0.5%-1% across the board. Trade concerns remain the focal point for market participants, with the latest controversy over U.S. immigration policy posing a potential threat to relations with traditional American allies abroad as well. Even with worries on a big-picture level, some individual companies had good news that sent their shares higher. Stitch Fix (NASDAQ:SFIX), Barnes & Noble Education (NYSE:BNED), and Heron Therapeutics (NASDAQ:HRTX) were among the best performers on the day. Here’s why they did so well.

  • [By Logan Wallace]

    Headlines about Heron Therapeutics (NASDAQ:HRTX) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Heron Therapeutics earned a media sentiment score of 0.23 on Accern’s scale. Accern also gave media headlines about the biotechnology company an impact score of 48.1976713050328 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Joseph Griffin]

    Rhumbline Advisers grew its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 20.7% in the second quarter, Holdings Channel reports. The fund owned 59,401 shares of the biotechnology company’s stock after acquiring an additional 10,173 shares during the period. Rhumbline Advisers’ holdings in Heron Therapeutics were worth $2,308,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Heron Therapeutics Inc (NASDAQ:HRTX) – Equities researchers at Cantor Fitzgerald issued their FY2019 earnings per share (EPS) estimates for shares of Heron Therapeutics in a report issued on Thursday, July 19th. Cantor Fitzgerald analyst L. Chen anticipates that the biotechnology company will post earnings of ($0.23) per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $50.00 price objective on the stock.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Heron Therapeutics (HRTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Value Stocks For 2019: FirstService Corporation(FSV)

Advisors’ Opinion:

  • [By Logan Wallace]

    FirstService Corp (TSE:FSV) (NASDAQ:FSV) declared a quarterly dividend on Wednesday, September 12th, Zacks reports. Shareholders of record on Friday, September 28th will be given a dividend of 0.176 per share on Friday, October 5th. This represents a $0.70 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Thursday, September 27th. This is a positive change from FirstService’s previous quarterly dividend of $0.17.

  • [By Shane Hupp]

    ILLEGAL ACTIVITY NOTICE: “BB&T Securities LLC Acquires 1,782 Shares of FirstService Corp (FSV)” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at www.tickerreport.com/banking-finance/4158310/bbt-securities-llc-acquires-1782-shares-of-firstservice-corp-fsv.html.

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY NOTICE: “FirstService (FSV) Set to Announce Quarterly Earnings on Wednesday” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at www.tickerreport.com/banking-finance/4123840/firstservice-fsv-set-to-announce-quarterly-earnings-on-wednesday.html.

Best Value Stocks For 2019: Cross Country Healthcare, Inc.(CCRN)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Cross Country Healthcare (NASDAQ:CCRN)‘s stock had its “hold” rating restated by equities research analysts at Cantor Fitzgerald in a report issued on Wednesday. They currently have a $10.00 target price on the business services provider’s stock. Cantor Fitzgerald’s price target points to a potential downside of 15.68% from the stock’s current price.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Value Stocks To Own For 2018

Leave a reply

For many people, homeownership is a major life goal, and they spend years saving to purchase their first home. But should owning a home come at the expense of other financial goals, like saving for retirement?

The answer is no. But a January 2017 Bankrate survey found that, in fact, more than one in three mortgages has a major impact on the borrower’s ability to save. And that may mean they spent too much on their house and their mortgage payments are too high.

If the 2008 financial crisis taught us anything, it’sthat a home should not be viewed solely as an investment that will always appreciate in value. Nor should it be regarded as a retirement asset. A home is an illiquid asset that you live in, and like any other investment, it can increase and decrease in value. And even if it does appreciate in value, you can only realize that gain if you sell it at the right time for the right price.

So, if you are in the market for a home, here are some guidelines to follow as you navigate the homebuying process to guard against your home being a barrier between you and a comfortable retirement.

Best Value Stocks To Own For 2018: Knowles Corporation(KN)

Advisors’ Opinion:

  • [By Jack Delaney]

    A deal with Facebook Inc. (Nasdaq: FB) brought the little-known Knowles Corp. (NYSE: KN) to investors’ attention today, boosting Knowles Corp. stock by 2.3% as of 12:30 p.m. today (Oct. 30, 2017).

Best Value Stocks To Own For 2018: Staffing 360 Solutions, Inc.(STAF)

Advisors’ Opinion:

  • [By Bryan Murphy]

    Look out ManpowerGroup Inc. (NYSE:MAN). And Robert Half International Inc. (NYSE:RHI)? You may want to look over your shoulder as well. A young-and-hungry staffing solutions competitor named Staffing 360 Solutions Inc (NASDAQ:STAF) is coming on strong, and just proved it again today. Some of its preliminary fiscal Q2 numbers were reported today, and they extend what’s become a long-term growth streak.

    The definition of a roll-up isn’t a hard and fast one, though even the broad brush strokes paint a pretty clear picture. Investopedia defines a roll-up (also known as a “roll up” or a “rollup”) a merger that occurs when investors (often private equity firms) buy up companies in the same market and merge them together. Roll-ups combine multiple small companies into something bigger and better to be able to enjoy economies of scale. Private equity firms use roll-ups to rationalize competition in crowded and/or fragmented markets and to combine companies with complementary capabilities into a full-service business.

    It’s also the kind of strategy Staffing 360 Solutions is executing, with great success. For the fiscal quarter ending in November, Staffing 360 Solutions has pre-reported revenue of $47 million, and a gross profit of $8.1 million. Those figures are up 14% and 8%, respectively, year-over-year.

  • [By Bryan Murphy]

    The staffing industry – and the IT staffing industry in particular – is poised for tremendous growth in the foreseeable future, and that rising tide bodes very well for Staffing 360 Solutions Inc. (NASDAQ:STAF).

  • [By Matthew Briar]

    If there was any lingering doubt about Staffing 360 Solutions Inc (NASDAQ:STAF), it was wiped away today. The IT staffing firm’s second quarter numbers verify the long-standing growth trend is still well intact. Better still, even as the top line rises, expense-cuts supported by all the synergies of its recent acquisitions have allowed the bottom line to improve by even more.

    Even before today’s official Q2 announcement we knew that last quarter’s revenue would roll in at $47.1 million and gross profits would end up at $8.1 million. Those figures were up 14% and 8.4%, respectively. What we didn’t know about STAF until today is that the net loss shrank from $3.4 million a year earlier to only $1.5 million now. EBITDA of $1.4 million was about the same as the EBITDA of $1.3 million generated in the second fiscal quarter of the prior year.

    The progress march continues for Staffing 360 Solutions.

Best Value Stocks To Own For 2018: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Best Value Stocks To Own For 2018: Heico Corporation(HEI)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Heico Corp (HEI) announced on Thursday that it has agreed to purchase Lucix Corp, a manufacturer of military satellite, airborne, and ground systems.

    The terms of the deal were not disclosed, but HEI revealed that the acquisition could be completed within 60 days. The deal is expected to impact HEI’s earnings within the first year.

    Heico shares were up 67 cents, or 1.04%, during Thursday morning trading. The stock is up 46% YTD.

  • [By Monica Gerson]

    Heico Corp (NYSE: HEI) is estimated to post its quarterly earnings at $0.54 per share.

    Exa Corp (NASDAQ: EXA) is projected to post a quarterly loss at $0.08 per share on revenue of $16.68 million.

Best Value Stocks To Own For 2018: Markel Corporation(MKL)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a table of the 10 most expensive stocks trading on U.S. markets today:

    Company (Ticker)Price per ShareMarket CapBerkshire Hathaway Inc. (NYSE: BRK-A)$ 257,227.52$ 419.50 billionSeaboard Corp. (NYSEMKT: SEB)$ 3,760.00$ 4.48 billionNVR Inc. (NYSE: NVR)$ 1,944.23$ 7.19 billionThe Priceline Group Inc. (Nasdaq: PCLN)$ 1,727.94$ 80.82 billionMarkel Corp. (NYSE: MKL)$ 978.51$ 13.78 billionWhite Mountains Insurance Group Ltd. (NYSE: WTM)$ 935.01$ 4.25 billionAmazon.com Inc. (Nasdaq: AMZN)$ 846.08$ 408.27 billionAlphabet Inc. (Nasdaq: GOOGL)$ 844.06$ 582.85 billionAutoZone Inc. (NYSE: AZO)$ 744.26$ 21.04 billionIntuitive Surgical Inc. (Nasdaq: ISRG)$ 735.63$ 28.41 billion

  • [By Matthew Frankel]

    Markel (NYSE:MKL) has been referred to as a mini-Berkshire many times, and for good reason. The company uses the same general business model as Warren Buffett does at Berkshire, using the cash from its insurance businesses to buy stocks and entire companies.